OXLUMO® (lumasiran) Treats primary hyperoxaluria type 1 in children and adults with an approved RNAi medicine that lowers oxalate production, urinary oxalate, and blood oxalate.
Visit productCosigns Received
Be the first Cosign
Put your name behind OXLUMO® (lumasiran).
Add it to your Products I use list and share why you use it.